Genome BC has invested $1 million in Acuva Technologies through its Industry Innovation (I²) program.

The I² Fund provides commercialization support for companies developing innovative life science technologies that address biological challenges in key economic sectors in BC: Agriculture, Energy and Mining, Environment, Fisheries and Aquaculture, Forestry, and Human Health.

Access to safe drinking water contributes to improved health, reduced risk of waterborne diseases. Acuva’s compact, energy efficient UV-LED water treatment technology offers huge potential to address this global issue.

Acuva’s proprietary IntenseBeam technology, developed in partnership with UBC, combines the proven performance of UV disinfection with the energy efficiency of LEDs, maximizing available UV power through optical lensing.

This purifies drinking water with microbial disinfection rates up to 99.9999% to protect health and safety without adding any chemicals into the water.

“Our UV-LED water disinfection technology enables clean drinking water globally and protects health to improve lives, all while reducing the need for single-use plastic drinking water bottles,” said Manoj Singh, President & CEO of Acuva Technologies.

“This funding from Genome BC’s I2 Program will help Acuva’s rapid growth and achieve our vision of creating a positive global impact while addressing the need for safe drinking water.”